Profile data is unavailable for this security.
About the company
Kohjin Bio Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of bacterial testing media, in vitro diagnostic drugs, cell culture media, as well as contract cell processing. The Company operates through three segments. The Tissue Culture business segment develops, manufactures, and sells tissue culture media, including serum-free media used for research purposes in regenerative medicine and immunotherapy. The Microbiology business segment develops, manufactures, and sells a wide variety of microorganism detection media used for pathogen testing in the clinical and food fields, and quality testing in various fields such as pharmaceuticals and cosmetics. The Cell Processing business segment conducts cell processing operations under contract from medical institutions at facilities that have obtained permission to manufacture specified cell products based on the Regenerative Medicine Safety Act.
- Revenue in JPY (TTM)5.07bn
- Net income in JPY557.40m
- Incorporated1981
- Employees167.00
- LocationKohjin Bio Co Ltd5-1-3, ChiyodaSAKADO-SHI 350-0214JapanJPN
- Phone+81 492843781
- Fax+81 492844784
- Websitehttps://kohjin-bio.jp
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Delta-Fly Pharma Inc | 0.00 | -1.66bn | 2.66bn | 13.00 | -- | 12.84 | -- | -- | -153.26 | -153.26 | 0.00 | 17.06 | 0.00 | -- | -- | 0.00 | -288.88 | -88.06 | -369.76 | -97.02 | -- | -- | -- | -1,051.54 | -- | -- | 0.00 | -- | -- | -- | -20.41 | -- | -61.24 | -- |
| Perseus Proteomics Inc | 140.41m | -758.12m | 3.42bn | 32.00 | -- | 3.87 | -- | 24.37 | -51.42 | -51.42 | 9.52 | 59.98 | 0.0846 | 3.48 | 7.92 | 4,387,750.00 | -45.69 | -38.61 | -48.88 | -40.75 | 86.21 | 90.16 | -539.94 | -837.30 | 12.86 | -- | 0.00 | -- | 19.89 | 7.02 | 18.08 | -- | 95.88 | -- |
| Muromachi Chemicals Inc | 7.37bn | 364.59m | 5.53bn | 203.00 | 15.07 | 2.05 | 10.23 | 0.7502 | 89.59 | 89.59 | 1,819.39 | 658.42 | 1.23 | 3.81 | 5.84 | 36,304,700.00 | 6.09 | 5.99 | 8.66 | 10.36 | 29.85 | 29.90 | 4.95 | 4.89 | 1.76 | 18.37 | 0.4769 | 26.50 | 4.46 | 4.73 | -26.93 | 50.19 | 32.64 | -- |
| Symbio Pharmaceuticals Ltd | 1.31bn | -4.78bn | 5.83bn | 108.00 | -- | 4.25 | -- | 4.46 | -95.49 | -95.49 | 26.04 | 21.39 | 0.296 | 1.37 | 3.83 | -- | -108.11 | -19.84 | -140.91 | -24.15 | 72.45 | 74.71 | -365.25 | -26.66 | 2.74 | -44.43 | 0.6092 | -- | -46.69 | -15.23 | -24.59 | -- | -11.15 | -- |
| MEDRx Co Ltd | 128.08m | -937.37m | 5.94bn | 22.00 | -- | 2.90 | -- | 46.35 | -18.25 | -18.25 | 2.38 | 34.52 | 0.0578 | 0.0891 | 4.48 | -- | -42.29 | -48.18 | -44.11 | -51.18 | 99.06 | 98.18 | -731.84 | -1,002.97 | 23.40 | -319.43 | -- | -- | -50.34 | 2.16 | -16.19 | -- | 16.00 | -- |
| Kohjin Bio Co Ltd | 5.07bn | 557.40m | 6.12bn | 167.00 | 10.98 | 1.03 | 6.47 | 1.21 | 109.06 | 109.06 | 992.83 | 1,157.47 | 0.5768 | 3.51 | 4.58 | 30,386,960.00 | 6.34 | -- | 8.73 | -- | 43.01 | -- | 10.98 | -- | 1.49 | -- | 0.2443 | -- | 9.14 | -- | 106.44 | -- | -- | -- |
| COSMO BIO COMPANY, LIMITED | 10.77bn | 337.00m | 7.88bn | 174.00 | 22.03 | 0.7888 | 15.73 | 0.732 | 59.14 | 59.14 | 1,893.02 | 1,651.94 | 0.883 | 6.53 | 3.57 | -- | 2.74 | 4.41 | 3.24 | 5.24 | 34.39 | 35.52 | 3.10 | 4.88 | 4.46 | -- | 0.002 | 50.68 | 7.26 | 5.88 | 28.63 | -12.94 | 34.02 | 8.02 |
| Nippon Chemiphar Co Ltd | 32.52bn | 545.00m | 7.89bn | 855.00 | 12.26 | 0.3486 | 3.85 | 0.2426 | 151.00 | 151.00 | 9,009.80 | 5,309.46 | 0.6233 | 1.98 | 2.75 | 38,035,090.00 | 1.04 | 0.6794 | 1.44 | 0.9686 | 26.19 | 28.43 | 1.68 | 1.04 | 1.34 | -- | 0.4785 | 55.16 | 5.93 | 0.5075 | 263.33 | -7.58 | 32.85 | 0.00 |
| CellSource Co Ltd | 3.71bn | 10.66m | 7.91bn | 148.00 | 797.46 | 1.31 | 37.87 | 2.13 | 0.5003 | 0.5003 | 186.84 | 303.58 | 0.5265 | 5.91 | 11.31 | 25,077,400.00 | 0.1512 | 10.68 | 0.1613 | 11.89 | 56.24 | 64.88 | 0.2872 | 14.37 | 11.79 | 16.09 | 0.0093 | 20.88 | -14.78 | 14.87 | -95.52 | -47.76 | 8.90 | -- |
| Solasia Pharma KK | 429.00m | -876.00m | 8.08bn | 23.00 | -- | 4.51 | -- | 18.83 | -3.79 | -3.79 | 1.81 | 6.65 | 0.2447 | 1.84 | 2.13 | -- | -49.96 | -64.76 | -58.36 | -79.60 | 48.48 | 58.61 | -204.20 | -297.25 | 5.70 | -61.50 | 0.0514 | -- | 35.76 | -1.13 | 54.87 | -- | -- | -- |
| K Pharma Inc | 0.00 | -993.23m | 8.30bn | 17.00 | -- | 6.56 | -- | -- | -85.59 | -85.59 | 0.00 | 109.00 | 0.00 | 0.00 | -- | -- | -37.53 | -- | -38.74 | -- | -- | -- | -- | -- | 28.29 | -1,982.81 | 0.5424 | -- | -- | -- | -17.34 | -- | -- | -- |
| Wakamoto Pharmaceutical Co Ltd | 9.29bn | 298.60m | 10.90bn | 286.00 | 36.38 | 0.8984 | 14.72 | 1.17 | 8.60 | 8.60 | 267.77 | 348.39 | 0.6006 | 1.62 | 3.06 | 32,493,160.00 | 1.93 | -0.0678 | 2.22 | -0.0781 | 47.70 | 48.65 | 3.21 | -0.1246 | 2.42 | -- | 0.0082 | -- | 0.6595 | -6.53 | -40.86 | -- | 21.87 | -- |
| CellSeed Inc | 83.68m | -1.10bn | 12.20bn | 38.00 | -- | 9.25 | -- | 145.79 | -31.83 | -31.83 | 2.41 | 35.67 | 0.0409 | 0.6561 | 3.81 | -- | -54.00 | -46.88 | -59.08 | -50.95 | 51.09 | 53.64 | -1,319.46 | -593.85 | 5.81 | -- | 0.0949 | -- | -56.71 | -15.95 | -28.41 | -- | 21.04 | -- |
Data as of Feb 18 2026. Currency figures normalised to Kohjin Bio Co Ltd's reporting currency: Japanese Yen JPY
7.22%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Gordian Capital Singapore Pte Ltd.as of 01 Sep 2025 | 363.30k | 7.11% |
| Sumitomo Mitsui DS Asset Management Co., Ltd.as of 30 Sep 2025 | 5.50k | 0.11% |
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
